» Articles » PMID: 31996019

Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment

Overview
Date 2020 Jan 31
PMID 31996019
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Kawasaki disease (KD) is the leading cause of acute vasculitis and acquired heart disease in children in developed countries. Notably, KD is more prevalent in males than females. We previously established a key role for IL (interleukin)-1 signaling in KD pathogenesis, but whether this pathway underlies the sex-based difference in susceptibility is unknown. Approach and Results: The role of IL-1 signaling was investigated in the cell wall extract-induced experimental mouse model of KD vasculitis. Five-week-old male and female mice were injected intraperitoneally with PBS, cell wall extract, or a combination of cell wall extract and the IL-1 receptor antagonist Anakinra. Aortitis, coronary arteritis inflammation score and abdominal aorta dilatation, and aneurysm development were assessed. mRNA-seq (messenger RNA sequencing) analysis was performed on abdominal aorta tissue. Publicly available human transcriptomics data from patients with KD was analyzed to identify sex differences and disease-associated genes. Male mice displayed enhanced aortitis and coronary arteritis as well as increased incidence and severity of abdominal aorta dilatation and aneurysm, recapitulating the increased incidence in males that is observed in human KD. Gene expression data from patients with KD and abdominal aorta tissue of cell wall extract-injected mice showed enhanced expression and IL-1 signaling genes in males. Although the more severe IL-1β-mediated disease phenotype observed in male mice was ameliorated by Anakinra treatment, the milder disease phenotype in female mice failed to respond.

Conclusions: IL-1β may play a central role in mediating sex-based differences in KD, with important implications for the use of anti-IL-1β therapies to treat male and female patients with KD.

Citing Articles

Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease.

Tu X, Chen X, Xu L, Yang C, Li J, Liu Y J Inflamm Res. 2025; 18:3093-3103.

PMID: 40059947 PMC: 11889999. DOI: 10.2147/JIR.S506154.


Transcriptome meta-analysis of Kawasaki disease in humans and mice.

Gu W, Mirsaidi-Madjdabadi S, Ramirez Jr F, Simonson T, Makino A Front Pediatr. 2024; 12:1423958.

PMID: 39350793 PMC: 11440715. DOI: 10.3389/fped.2024.1423958.


The Central Role of Interleukin-1 Signalling in the Pathogenesis of Kawasaki Disease Vasculitis: Path to Translation.

Atici A, Noval Rivas M, Arditi M Can J Cardiol. 2024; 40(12):2305-2320.

PMID: 39084253 PMC: 11646188. DOI: 10.1016/j.cjca.2024.07.023.


Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by cell wall extract.

Lombardi Pereira A, Aubuchon E, Moreira D, Lane M, Carvalho T, Mesquita T Front Immunol. 2024; 15:1411979.

PMID: 38989288 PMC: 11234797. DOI: 10.3389/fimmu.2024.1411979.


Platelets in Kawasaki disease: mediators of vascular inflammation.

Noval Rivas M, Kocaturk B, Franklin B, Arditi M Nat Rev Rheumatol. 2024; 20(8):459-472.

PMID: 38886559 DOI: 10.1038/s41584-024-01119-3.


References
1.
Gorelik M, Lee Y, Abe M, Andrews T, Davis L, Patterson J . IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis. Clin Exp Immunol. 2019; 198(1):101-110. PMC: 6718290. DOI: 10.1111/cei.13314. View

2.
Maury C, Salo E, Pelkonen P . Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med. 1988; 319(25):1670-1. DOI: 10.1056/NEJM198812223192515. View

3.
Kuo H, Chang J, Kuo H, Yu H, Wang C, Lee C . Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. Arthritis Rheumatol. 2014; 67(3):828-36. DOI: 10.1002/art.38976. View

4.
Kwon Y, Kim J, Yun S, Yu J, Yoon K, Lee K . Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One. 2017; 12(9):e0184248. PMC: 5590908. DOI: 10.1371/journal.pone.0184248. View

5.
Salo E, Griffiths E, Farstad T, Schiller B, Nakamura Y, Yashiro M . Incidence of Kawasaki disease in northern European countries. Pediatr Int. 2012; 54(6):770-2. PMC: 3467350. DOI: 10.1111/j.1442-200X.2012.03692.x. View